Wang L, Liu N, Yao L, Li F, Zhang J, Deng Y, Liu J, Ji S, Yang A, Han H, Zhang Y, Zhang J, Han W, Liu X: NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol Biochem. 2008, 21: 239-250. 10.1159/000113765.
Article
CAS
PubMed
Google Scholar
Shen L, Zhao ZY, Wang YZ, Ji SP, Liu XP, Liu XW, Che HL, Lin W, Li X, Zhang J, Yao LB: Immunohistochemical detection of Ndrg2 in the mouse nervous system. Neuroreport. 2008, 19: 927-931. 10.1097/WNR.0b013e32830163d0.
Article
CAS
PubMed
Google Scholar
Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jaisser F, Blot-Chabaud M, Farman N, Courtois-Coutry N: Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem. 2002, 277: 31506-31515. 10.1074/jbc.M200272200.
Article
CAS
PubMed
Google Scholar
Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS: Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun. 2009, 385: 198-203. 10.1016/j.bbrc.2009.05.038.
Article
CAS
PubMed
Google Scholar
Hu XL, Liu XP, Lin SX, Deng YC, Liu N, Li X, Yao LB: NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol. 2004, 10: 3518-3521.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L: Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun. 2007, 358: 164-169. 10.1016/j.bbrc.2007.04.089.
Article
CAS
PubMed
Google Scholar
Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ, Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM, Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY, Yeom YI: Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 2008, 68: 4210-4220. 10.1158/0008-5472.CAN-07-5040.
Article
CAS
PubMed
Google Scholar
Wu GQ, Liu XP, Wang LF, Zhang WH, Zhang J, Li KZ, Dou KF, Zhang XF, Yao LB: Induction of apoptosis of HepG2 cells by NDRG2. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003, 19: 357-360.
CAS
PubMed
Google Scholar
Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J. 1998, 12: 1241-1251.
CAS
PubMed
Google Scholar
Droz D, Zachar D, Charbit L, Gogusev J, Chrétein Y, Iris L: Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol. 1990, 137: 895-905.
CAS
PubMed
PubMed Central
Google Scholar
Senner V, Sturm A, Baur I, Schrell UH, Distel L, Paulus W: CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol. 1999, 58: 795-802. 10.1097/00005072-199908000-00002.
Article
CAS
PubMed
Google Scholar
Kristiansen G, Schluns K, Yonwei Y, Denkert C, Dietel M, Petersen I: CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer. 2003, 88: 231-235. 10.1038/sj.bjc.6600702.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M: CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res. 2003, 9: 4906-4913.
CAS
PubMed
Google Scholar
Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, Leoning S, Rosenthal A, Dietel M: CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate. 2004, 58: 183-192. 10.1002/pros.10324.
Article
PubMed
Google Scholar
Kristiansen G, Denkert C, Schluns K, Dahl E, Pilarsky C, Hauptmann S: CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol. 2002, 161: 1215-1221. 10.1016/S0002-9440(10)64398-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA. 2001, 98: 1176-1181. 10.1073/pnas.98.3.1176.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lim SC, Oh SH: The role of CD24 in various human epithelial neoplasias. Pathol Res Pract. 2005, 201: 479-486. 10.1016/j.prp.2005.05.004.
Article
CAS
PubMed
Google Scholar
Huang LR, Hsu HC: Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res. 1995, 55: 4717-4721.
CAS
PubMed
Google Scholar
Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J: CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res. 2009, 15: 5518-5527. 10.1158/1078-0432.CCR-09-0151.
Article
CAS
PubMed
Google Scholar
Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ: Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res. 2008, 14: 2056-2064. 10.1158/1078-0432.CCR-07-1473.
Article
CAS
PubMed
Google Scholar
Hsu HC, Su IJ, Lai MY, Chen DS, Chang MH, Chuang SM, Sung JL: Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol. 1987, 50: 45-50.
Article
Google Scholar
Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY: Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res. 1993, 53: 4691-4694.
CAS
PubMed
Google Scholar
Bachman KE, Park BH: Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol. 2005, 17: 49-54. 10.1097/01.cco.0000143682.45316.ae.
Article
CAS
PubMed
Google Scholar
Pirruccello SJ, LeBien TW: The human B-cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunolol. 1986, 136: 3779-3784.
CAS
Google Scholar
Sagiv E, Arber N: The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Rev Gastroenterol Hepatol. 2008, 2: 125-133. 10.1586/17474124.2.1.125.
Article
CAS
PubMed
Google Scholar
Fidler IJ: Critical factors in the biology of human cancer metastasis: 28th G.H.A. Clowes memorial award lecture. Cancer Res. 1990, 50: 6130-6138.
CAS
PubMed
Google Scholar
Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP: CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 2005, 65: 10783-10793. 10.1158/0008-5472.CAN-05-0619.
Article
CAS
PubMed
Google Scholar
Lim SC: CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother. 2005, 59 (Suppl 2): 351-354.
Article
Google Scholar